Editorial: assessment of Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer, a prospective single arm clinical study: California shows the way!
作者信息
Choyke Peter
机构信息
Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.
出版信息
Transl Androl Urol. 2019 Jul;8(Suppl 3):S296-S299. doi: 10.21037/tau.2019.06.11.
Abstract
摘要
相似文献
1
Editorial: assessment of Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer, a prospective single arm clinical study: California shows the way!社论：评估镓-PSMA-11 PET在定位复发性前列腺癌中的准确性，一项前瞻性单臂临床研究：加利福尼亚州指明了方向！
Transl Androl Urol. 2019 Jul;8(Suppl 3):S296-S299. doi: 10.21037/tau.2019.06.11.
2
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.68Ga-PSMA-11 PET 定位复发性前列腺癌的准确性评估：一项前瞻性单臂临床试验。
JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.
3
Re: Assessment of Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.关于：镓-PSMA-11正电子发射断层扫描在定位复发性前列腺癌中的准确性评估：一项前瞻性单臂临床试验。
Eur Urol. 2019 Oct;76(4):538-539. doi: 10.1016/j.eururo.2019.05.016. Epub 2019 May 23.
4
Establishment and prospective validation of an SUV cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by Ga-PSMA PET/CT: a real-world study.应用 Ga-PSMA PET/CT 建立并前瞻性验证 SUV 截断值以鉴别疑似前列腺癌患者中由前列腺特异性膜抗原 PET/CT 检测的临床显著前列腺癌与良性前列腺疾病：一项真实世界研究。
Theranostics. 2021 Jul 25;11(17):8396-8411. doi: 10.7150/thno.58140. eCollection 2021.
5
The Impact of Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study.镓-PSMA PET/CT 对前列腺癌管理意向的影响：一项澳大利亚前瞻性多中心研究的结果。
J Nucl Med. 2018 Jan;59(1):82-88. doi: 10.2967/jnumed.117.197160. Epub 2017 Jun 23.
6
Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.镓-PSMA-11 PET/CT 在复发性前列腺癌中的应用：根治性治疗后 PSA 失败不同临床阶段的疗效。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):31-39. doi: 10.1007/s00259-018-4189-7. Epub 2018 Oct 22.
7
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值：与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
8
F-fluciclovine PET-CT and Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.氟[¹⁸F]氟代脱氧葡萄糖 PET-CT 和镓[⁶⁸Ga]前列腺特异性膜抗原-11 PET-CT 在前列腺癌根治术后早期生化复发患者中的应用：一项前瞻性、单中心、单臂、对比成像试验。
Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30.
9
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
10
Multiphasic Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients.多期 Ga-PSMA PET/CT 在 PSA 水平<1ng/mL 的前列腺癌患者早期复发检测中的应用：一项对 135 例患者的前瞻性研究。
J Nucl Med. 2020 Oct;61(10):1484-1490. doi: 10.2967/jnumed.119.238071. Epub 2020 Feb 14.
引用本文的文献
1
Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse.前列腺癌复发的影像学评估：局部和全身复发检测的进展
Abdom Radiol (NY). 2025 Feb;50(2):807-826. doi: 10.1007/s00261-024-04412-7. Epub 2024 Sep 10.
2
Interobserver agreement of [Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer.[镓]Ga-PSMA-11 PET/CT图像解读在新诊断前列腺癌男性患者中的观察者间一致性。
EJNMMI Res. 2020 Feb 28;10(1):15. doi: 10.1186/s13550-020-0596-4.
本文引用的文献
1
A Prospective Study on F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer.前列腺癌生化复发中 F-DCFPyL PSMA PET/CT 成像的前瞻性研究。
J Nucl Med. 2019 Nov;60(11):1587-1593. doi: 10.2967/jnumed.119.226381. Epub 2019 Apr 12.
2
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.68Ga-PSMA-11 PET 定位复发性前列腺癌的准确性评估：一项前瞻性单臂临床试验。
JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.
3
Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.前列腺影像报告和数据系统第2版在前列腺MRI检测和评估前列腺癌病灶中的阅片者间变异性
AJR Am J Roentgenol. 2019 Jun;212(6):1197-1205. doi: 10.2214/AJR.18.20536. Epub 2019 Mar 27.
4
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors.维生素 B9 的前列腺特异性膜抗原裂解通过代谢型谷氨酸受体刺激致癌信号。
J Exp Med. 2018 Jan 2;215(1):159-175. doi: 10.1084/jem.20171052. Epub 2017 Nov 15.
5
Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.镓-PSMA-11（HBED-CC）PET/CT对复发性前列腺癌患者的诊断效能：1007例患者的评估
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268. doi: 10.1007/s00259-017-3711-7. Epub 2017 May 12.
6
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.复发前列腺癌患者中[(18)F]DCFPyL与[(68)Ga]Ga-PSMA-HBED-CC用于PSMA-PET成像的比较
Mol Imaging Biol. 2015 Aug;17(4):575-84. doi: 10.1007/s11307-015-0866-0.
7
Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.⁶⁸Ga-PSMA配体杂交正电子发射断层显像/计算机断层扫描在248例前列腺癌根治术后生化复发患者中的评估
J Nucl Med. 2015 May;56(5):668-74. doi: 10.2967/jnumed.115.154153. Epub 2015 Mar 19.
8
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.（68）镓标记的前列腺特异性膜抗原（PSMA）配体HBED-CC的PET/CT成像在复发性前列腺癌诊断中的价值
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209. doi: 10.1007/s00259-014-2949-6. Epub 2014 Nov 20.
9
Integrative genomic profiling of human prostate cancer.人类前列腺癌的综合基因组分析。
Cancer Cell. 2010 Jul 13;18(1):11-22. doi: 10.1016/j.ccr.2010.05.026. Epub 2010 Jun 24.
Zotero 插件